IRIS
RIPA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 478
NA - Nord America 442
AS - Asia 87
AF - Africa 7
SA - Sud America 3
OC - Oceania 2
Totale 1.019
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 436
SE - Svezia 275
IT - Italia 131
CN - Cina 40
FI - Finlandia 22
DE - Germania 20
SG - Singapore 11
IN - India 9
PK - Pakistan 6
FR - Francia 5
IE - Irlanda 5
IR - Iran 5
GB - Regno Unito 4
JP - Giappone 4
PH - Filippine 4
UA - Ucraina 4
BR - Brasile 3
CA - Canada 3
HR - Croazia 3
MX - Messico 3
NL - Olanda 3
SA - Arabia Saudita 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BE - Belgio 2
MY - Malesia 2
TN - Tunisia 2
CH - Svizzera 1
DZ - Algeria 1
EG - Egitto 1
ES - Italia 1
HK - Hong Kong 1
MK - Macedonia 1
PL - Polonia 1
Totale 1.019
Salva come PNG Salva come JPEG
Città #
New York 70
Lawrence 60
Ashburn 59
Princeton 59
Shanghai 37
Milan 24
Helsinki 21
Rome 14
Seattle 12
Washington 9
Huskvarna 8
Genoa 6
Lahore 6
Padova 5
Pune 5
Turin 5
Vittoria 5
Fremont 4
Quezon City 4
Thetford 4
Angera 3
Ballincollig 3
Borås 3
Durban 3
Hanover 3
Lviv 3
Mexico City 3
Zagreb 3
Al Qatif 2
Anzio 2
Bari 2
Casorezzo 2
Dubai 2
Dublin 2
Florence 2
Ghent 2
Hyderabad 2
Los Angeles 2
Mahestan 2
Naaldwijk 2
Rio de Janeiro 2
Sacramento 2
Segrate 2
Seremban 2
Singapore 2
Torre Del Greco 2
Varedo 2
Verona 2
Witten 2
Amsterdam 1
Andover 1
Boardman 1
Cairo 1
Cuneo 1
Falkenstein 1
Forlì 1
Isfahan 1
Jeddah 1
Kashan 1
Lainate 1
Lappeenranta 1
Littleton 1
Madrid 1
Missaglia 1
Montréal 1
Palermo 1
Paliano 1
Paris 1
Pavia 1
Reggio Calabria 1
San Donà di Piave 1
San Sperate 1
Santa Clara 1
Skopje 1
Springfield 1
Strullendorf 1
Sydney 1
Toronto 1
Truccazzano 1
Ventimiglia 1
Winnipeg 1
Étagnières 1
Totale 516
Salva come PNG Salva come JPEG
Nome #
Impact of Levofloxacin for Prophylaxis of Pre-engraftment Bloodstream Infections after Allogeneic HSCT: A single-center Matched Analysis in an Endemic Country for Carbapenem-resistant Gram-negative Bacteria 57
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 41
Outcomes of non-invasive ventilation as the ceiling of treatment in patients with COVID-19 35
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia 31
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 30
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 27
Interleukin 1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study 26
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 25
Biobanking for COVID-19 research 25
One-Year Multidisciplinary Follow-Up of Patients With COVID-19 Requiring Invasive Mechanical Ventilation 23
The Elephant in the Room: Secondary Infections and Antimicrobial Use in Patients With COVID-19 23
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB 22
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase 22
The spectrum of covid-19-associated myocarditis: A patient-tailored multidisciplinary approach 22
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 22
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study 20
Pulmonary Vascular Thrombosis in COVID-19 Pneumonia 20
LC-MS/MS method for simultaneous determination of linezolid, meropenem, piperacillin and teicoplanin in human plasma samples 19
Allogeneic bone marrow transplantation in HIV people with hematological malignancies: Post-transplant cyclophosphamide to overcome the HLA-matching barrier 19
Subclinical myocardial dysfunction in patients recovered from COVID-19 19
Frailty as a predictor of mortality in COVID-19 patients receiving CPAP for respiratory insufficiency 19
Dynamics of adaptive and innate immunity inpatients treated during primary human immunodeficiency virus infection: Results from Maraviroc in HIV Acute Infection (MAIN) randomized clinical trial 18
The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry 18
Circulating cathodic antigen (CCA) urine rapid test for diagnosis of Schistosoma mansoni infestation: preliminary data of a cohort study of Egyptian patients coming from an endemic area 18
Ceftobiprole for the treatment of infective endocarditis: A case series 18
Cardiac implantable electronic device infections: impact of initiation of antimicrobial treatment before or after device removal on microbiological yield 17
Myocardial injury in patients with SARS-CoV-2 pneumonia: pivotal role of inflammation in COVID-19 17
Invasive fungal infections in patients with COVID-19: a review on pathogenesis, epidemiology, clinical features, treatment, and outcomes 17
48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study 16
Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients 16
Bowel perforation in a Covid-19 patient: case report 16
Infections after Allogenic Transplant with Post-Transplant Cyclophosphamide: Impact of Donor HLA Matching 16
Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement. 16
Clinical characteristics and outcome of infective endocarditis due to Abiotrophia and Granulicatella compared to Viridans group streptococci 16
Enhanced immunological recovery with early start of antiretroviral therapy during acute or early HIV infection–results of Italian network of acute HIV infection (Inaction) retrospective study 16
Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: A prospective cohort study 15
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses 14
Beneficial effects of cART initiated during primary and chronic HIV-1 infection on immunoglobulin-expression of memory B-cell subsets 14
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection 13
Estimated glomerular filtration rate trajectories in HIV-infected subjects treated with different ritonavir-boosted protease inhibitors and tenofovir disoproxil fumarate or abacavir 13
Homeostatic model assessment for insulin resistance index trajectories in HIV-infected patients treated with different first-line antiretroviral regimens 13
Clinical Features and Outcomes of Streptococcus anginosus Group Infective Endocarditis: A Multicenter Matched Cohort Study 13
Role of Rehabilitation Department for Adult Individuals With COVID-19: The Experience of the San Raffaele Hospital of Milan 13
Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort 13
Disseminated Mycobacterium chimaera infection favoring the development of Kaposi’s sarcoma: a case report 12
High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation 12
Antibiotic appropriateness for Gram-negative bloodstream infections: impact of infectious disease consultation 12
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection-authors' response 12
Eosinophils from Physiology to Disease: A Comprehensive Review 11
Immunosenescence and hurdles in the clinical management of older HIV-patients 10
Rugarli. Medicina interna sistematica 10
Genetic characterization of Klebsiella pneumoniae carbapenemase -producing Klebsiella pneumoniae isolates with different susceptibility to ceftazidime/avibactam in patients with blood-stream infections 9
Post-neurosurgical Nocardia meningoventriculitis: a case report and review of the literature 9
Time spent with residual viraemia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimen 9
Evaluation of ceftazidime/avibactam for serious infections due to multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa 9
Influence of empirical double-active combination antimicrobial therapy compared with active monotherapy on mortality in patients with septic shock: A propensity score-adjusted and matched analysis-authors' response 9
Rugarli. Medicina interna sistematica 9
Immunological Recovery After 24 Weeks of Antiretroviral Therapy in Patients With X4 Virus During Primary HIV Infection 8
Four-year outcome of a PI and NRTI-sparing salvage regimen: maraviroc, raltegravir, etravirine 8
Influence of empirical double-active combination antimicrobial therapy compared with active monotherapy on mortality in patients with septic shock: A propensity score-adjusted and matched analysis 8
Soluble endothelial protein C receptor (sEPCR) as an inflammatory biomarker in naive HIV-infected patients during ART 8
Maraviroc 150mg daily plus lopinavir/ritonavir, a nucleoside/nucleotide reverse transcriptase inhibitor-sparing regimen for HIV-infected naive patients: 48-week final results of VEMAN study 8
Performance of commonly used genotypic assays and comparison with phenotypic assays of HIV-1 coreceptor tropism in acutely HIV-1-infected patients 7
Viral rebound after switch to maraviroc/raltegravir dual therapy in highly experienced and virologically suppressed patients with HIV-1 infection 7
Invasive Pulmonary Aspergillosis Complicated by Carbapenem-Resistant Pseudomonas aeruginosa Infection During Pembrolizumab Immunotherapy for Metastatic Lung Adenocarcinoma: Case Report and Review of the Literature 7
Maraviroc in addition to cART during primary HIV infection: Results from MAIN randomized clinical trial and 96-weeks follow-up 7
Short-term peripheral venous catheter-related bloodstream infections: Evidence for increasing prevalence of Gram-negative microorganisms from a 25-year prospective observational study 7
Pustulosis acuta generalisata following chemotherapy in an HIV-positive patient 7
Real-life experience with remdesivir for treatment of COVID-19 among older adults: a multicentre retrospective study 6
Impact of surgical timing on survival in patients with infective endocarditis: a time-dependent analysis 5
Predictors of survival in elderly patients with coronavirus disease 2019 admitted to the hospital: derivation and validation of the FLAMINCOV score 4
Risk factors for Gram-negative bacterial infection of cardiovascular implantable electronic devices: multicentre observational study (CarDINe Study) 3
Totale 1.136
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.458
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.458
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209 1 0 0 0 0 0 0 0 0 0 6 2
2020/202132 1 0 0 5 0 12 1 10 1 0 2 0
2021/2022151 1 0 3 31 13 15 16 13 10 6 7 36
2022/2023482 136 113 22 9 20 63 16 52 14 10 17 10
2023/2024437 17 45 92 37 52 111 11 49 5 17 1 0
Totale 1.136